March 15 - 16, 2017
Experience a public-facing dialogue exploring the nuanced ethical and scientific rationale behind randomized controlled clinical trials, accelerated alternatives, and the implications of these discussions on drug approval and patient interests.
Thursday, November 3, 2016 | 9:00 AM - 5:00 PM
Speakers: Henrik Bjørn Nielsen (Clinical-Microbiomics A/S), Martin J. Blaser (New York University Langone Medical Center), Patrice D. Cani (Universite Catholique de Louvain, LDRI), Rachel Carmody (Harvard University), Stanley L. Hazen (Cleveland Clinic), Gerald I. Shulman (Yale University School of Medicine), Marion Soto (Joslin Diabetes Center, Harvard Medical School), and Dan Winer (University of Toronto)
The microbiome is emerging as an important regulator of health, and disease well beyond the digestive tract. This symposium will highlight recent research innovations and therapeutic applications from the microbiome with a focus on metabolic disease.
Friday, September 16, 2016 | 8:30 AM - 6:00 PM
Speakers: Lori B. Andrews (Chicago-Kent College of Law, Illinois Institute of Technology), Gary Bennett (Duke University), Barbara E. Millen (Millennium Prevention, Inc.), Tooraj Mirshahi (Geisinger Clinic), Satchidananda Panda (SALK Institute), Ruth E. Patterson (University of California San Diego), Michael K. Price (Georgia State University), Karandeep Singh (University of Michigan), and Nicholas Tatonetti (Columbia University)
Researchers, health professionals, and a growing wellness-conscious public use technology to monitor health status. Big Data harnessed from this technology have created a foundation for focused research targeting obesity, but at what cost?
Friday, June 3, 2016 | 8:30 AM - 6:00 PM
Speakers: Agnes C. Agunos (Public Health Agency of Canada), Seamus Fanning (University College Dublin), Delia Grace (International Livestock Research Institute), William J. Hall (Wellcome Trust), Francois Malouin (Sherbrooke University), James L. Marsden (Chipotle Mexican Grill), Alan G. Mathew (Purdue University), H. Morgan Scott (Texas A&M University), Stacy E. Sneeringer (USDA), Jaap A. Wagenaar (Utrecht University), and David R. Wolfgang (Pennsylvania State University)
Antibiotics have been used in human and animal medicine for decades. Reducing the use of antibiotics changes the dynamic between the food supply, food safety, and public health. Food safety practices may emerge a catalyst for change.
Thursday, May 26, 2016 | 9:00 AM - 6:00 PM
Featured Speaker: Peter Godfrey-Faussett (UNAIDS)
This event will address the incidence of non-communicable diseases among people living with HIV, describe morbidity and mortality, and explore interactions among HIV, antiretroviral drugs and behavioral factors influencing development and treatment.
Edited by Charles W. Fox
(University of Kentucky) and Timothy A. Mousseau
(University of South Carolina)
Eleven scholarly review articles discuss topics in evolutionary biology and genetics
Edited by Gerald D. Wright
Nine scholarly review articles discussing aspects of antibiotic resistance
Organizers: Gary R. Acuff (Texas A&M University), Robert Brackett, (Illinois Institute of Technology), Sarah Marie Cahill (Food and Agriculture Organization of the United Nations), Bruce Cogill (Consultant), Jeffrey Farber (University of Guelph), Gilles Bergeron (The Sackler Institute for Nutrition Science), and Mireille Mclean (The Sackler Institute for Nutrition Science)
This one-day conference reviewed the implications of antibiotic use in the food system from veterinary health, human health, food safety, and food system economic perspectives.
Edited by Annals of the New York Academy of Sciences
This special issue presents a collection of four papers ranging from proapoptotic and antiangiogentic properties of resveratrol, to executive function of in adults with beta-thalassemia, to disease drivers of aging.